PMID- 18382220
OWN - NLM
STAT- MEDLINE
DCOM- 20080724
LR  - 20191210
IS  - 0951-7367 (Print)
IS  - 0951-7367 (Linking)
VI  - 21
IP  - 3
DP  - 2008 May
TI  - Ecstasy and other club drugs: a review of recent epidemiologic studies.
PG  - 234-41
LID - 10.1097/YCO.0b013e3282f9b1f1 [doi]
AB  - PURPOSE OF REVIEW: This review highlights the epidemiologic research on club drug 
      use in the past year, with a focus on clinical epidemiology, social epidemiology, 
      new methodological approaches, and alternative explanations for drug use 
      behaviors. RECENT FINDINGS: Although 3,4-methylenedioxy-N-methylamphetamine 
      (MDMA) or ecstasy is currently classified as a type of hallucinogen and its 
      withdrawal is not recognized in the Diagnostic and Statistical Manual of Mental 
      Disorders, there is evidence for the association of withdrawal symptoms with MDMA 
      abstinence. Findings from latent class analysis indicate that MDMA users have a 
      significantly higher risk of dependence than lysergic acid diethylamide users. 
      Research on sociodemographic factors associated with club drug use continues to 
      be a main focus worldwide. New epidemiologic research methods have been developed 
      to enable researchers to monitor real-time drug use behaviors and to conduct 
      surveys on sensitive issues in public places. In addition to traditional 
      behavioral models, researchers began to examine the club drug phenomenon in the 
      context of economic environment. SUMMARY: Recent findings on MDMA use further 
      question the current drug classification in the diagnostic systems. Despite the 
      continuous growth in the club drug research literature, there is no study on the 
      influence of genetic factors on club drug use. More research in this area is 
      needed.
FAU - Leung, Kit Sang
AU  - Leung KS
AD  - Epidemiology and Prevention Research Group, Department of Psychiatry, Washington 
      University School of Medicine, St Louis, Missouri 63108, USA. 
      leungks@epi.wustl.edu
FAU - Cottler, Linda B
AU  - Cottler LB
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Review
PL  - United States
TA  - Curr Opin Psychiatry
JT  - Current opinion in psychiatry
JID - 8809880
RN  - 0 (Illicit Drugs)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - Australia/epidemiology
MH  - Costa Rica/epidemiology
MH  - Guatemala/epidemiology
MH  - Hong Kong/epidemiology
MH  - Humans
MH  - *Illicit Drugs
MH  - Israel/epidemiology
MH  - Italy/epidemiology
MH  - *N-Methyl-3,4-methylenedioxyamphetamine
MH  - Panama/epidemiology
MH  - Substance-Related Disorders/*epidemiology
MH  - Sweden/epidemiology
MH  - Taiwan/epidemiology
MH  - United Kingdom/epidemiology
MH  - United States/epidemiology
RF  - 44
EDAT- 2008/04/03 09:00
MHDA- 2008/07/25 09:00
CRDT- 2008/04/03 09:00
PHST- 2008/04/03 09:00 [pubmed]
PHST- 2008/07/25 09:00 [medline]
PHST- 2008/04/03 09:00 [entrez]
AID - 00001504-200805000-00003 [pii]
AID - 10.1097/YCO.0b013e3282f9b1f1 [doi]
PST - ppublish
SO  - Curr Opin Psychiatry. 2008 May;21(3):234-41. doi: 10.1097/YCO.0b013e3282f9b1f1.